📜 iter-4360dd15-0108.log
20833 bytes
# Iter-0108 mission=4360dd15
# goal: 找到让人类长生不老的方法
# time: 2026-04-26T03:21:59
# focus_node: root :: 找到让人类长生不老的方法
========== TRANSCRIPT ==========
→ call task_view({"max_depth":6})
【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n► [✓ done ] root: 找到让人类长生不老的方法\n├─ [✓ done ] n1: 建立 marker 锚定后的局部交换判定框架 ← 已完成 marker 锚定后的局部交换判定框架：固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口，并在触及 wit\n│ ├─ [✓ done ] n5: 规范化 witness：固定 μ 锚点并限制一次交换的位置 ← 完成 witness 规范化：确认固定 μ 锚点时必须排除触碰 μ 的交换，并用 greedy witness span 将允许交换压缩到局部窗口内；小规模穷举\n│ │ ├─ [✓ done ] n9: 证伪一次交换跨越 μ 的规范化可能性 ← 用穷举验证并归纳出结构性事实：任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1，因此在固定 μ 位置的 witness 规范化里，不存在“跨\n│ │ ├─ [✓ done ] n10: 把单侧交换位置压缩为可判定窗口 ← 证明并穷举验证：对左块 greedy witness 的最左/最右嵌入位置 p1..pk，窗口外相邻交换不会改变最大前缀消耗 k，因此允许交换位置可压缩为 [p\n│ │ └─ [✓ done ] n11: 沉淀 witness 规范形模板 ← 沉淀出 witness 规范形模板：固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口，并用左块最大前缀消耗 k 作\n│ ├─ [✓ done ] n6: 建立单侧切分判定接口：把可行性压成存在切分点 k ← 把固定 μ 锚点后的可行性压成了单侧切分接口：左块只通过最大前缀消耗长度 k 传递，且 k 由 X 决定、与 Y 无关。\n│ ├─ [✓ done ] n7: 刻画交换不依赖右侧的充分条件 ← 验证了一个可复用充分条件：若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k，则对所有右侧 Y 的可行性判定保持不变；并用穷举检查了 small-case \n│ ├─ [✓ done ] n8: 沉淀可复用的验证模板与失败边界 ← 找到验证模板的失败边界：任意 witness span 不够，必须用 greedy witness span；给出反例 X=abb, S=ba，窗口外交换仍可改\n│ ├─ [✓ done ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界 ← 在二元字母表、长度 n<=8 的穷举中，未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例；这给出了多交换局部性边\n│ ├─ [✓ done ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程 ← 完成了一个可执行的局部交换检查流程：先算 k，再用 greedy witness span 的局部闭包限制候选交换；对二元字母表、|X|<=8、|S|<=8 的\n│ ├─ [✓ done ] n14: 证伪 greedy witne
→ call task_current({})
【tool:task_current】
{"ok": true, "id": "root", "title": "找到让人类长生不老的方法", "rationale": "总目标", "status": "done", "result": "完成了对体外/器官类系统的顺序实验补充检索，未发现 senolytic 预处理后再做 OSK/partial reprogramming 的原始研究，证据缺口进一步扩大到 ex vivo 体系。", "path": ["找到让人类长生不老的方法"], "children": [{"id": "n1", "title": "建立 marker 锚定后的局部交换判定框架", "status": "done"}, {"id": "n2", "title": "证明左侧一次相邻交换的切分判定引理", "status": "done"}, {"id": "n3", "title": "刻画交换不依赖右侧的 witness 规范化条件", "status": "done"}, {"id": "n4", "title": "沉淀可复用的 predicate verification 方法论", "status": "done"}, {"id": "n15", "title": "凝练 marker 锚定局部交换框架为统一定理与检查协议", "status": "done"}, {"id": "n30", "title": "识别人类寿命上限的首要生物学瓶颈并提出可检验干预假设", "status": "done"}, {"id": "n36", "title": "比较并筛选第二个可检验的长寿瓶颈候选", "status": "done"}, {"id": "n37", "title": "用统一因果干预与安全读出比较表观遗传信息损失与细胞衰老", "status": "done"}, {"id": "n38", "title": "证伪视网膜 OSK 证据可作为长寿主路线的代表性：找同组织同读出头对头比较", "status": "done"}, {"id": "n39", "title": "锁定一个组织内的 OSK vs senolytic 同组织同终点证据地图", "status": "done"}, {"id": "n40", "title": "检索皮肤中 OSK vs senolytic 的原始头对头证据", "status": "done"}, {"id": "n44", "title": "寻找另一种组织中的 OSK vs senolytic 直接 head-to-head 原始证据", "status": "failed"}, {"id": "n45", "title": "定义 OSK vs senolytic 的最小可比实验规格", "status": "done"}, {"id": "n46", "title": "设计路由匹配的皮肤 OSK vs ABT-263 对照实验", "status": "done"}, {"id": "n47", "title": "把皮肤 OSK vs ABT-263 蓝图收敛成可执行参数表并做反证式审稿", "status": "done"}, {"id": "n52", "title": "补全皮肤 ABT-263 原始研究的精确参数并与 OSK 对齐", "status": "done"}, {"id": "n53", "title": "补齐皮肤 ABT-263 原始研究准确题名与完整参数", "
→ call search_memory({"limit":8,"mission_only":true,"query":"senolytic reprogramming preconditioning OSK senescence niche"})
【tool:search_memory】
{"ok": true, "results": [{"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率；在某些组织里，senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "relevance-drifting: 直接回到一个最窄的生物学问题：在同一组织中是否存在“先 senolytic、后 OSK”且同时报告功能改善与安全性读出的", "tags": "iteration relevance-check drifting", "mission": "4360dd15", "modified": "20260425172359000", "preview": "!! 目标相关性校准（drifting） verdict: **drifting** reason: 当前工作仍在为筛选可能的组织再生/抗衰老干预做证据核验，但最近几条标题已经明显转向检索约束、空检索和字段收缩这类方法论自转，离“找到让人类长生不老的方法”至少隔着数层证据筛选链条。 anchor_title: 检索要用字段收缩来验证结构性空集 rebase_focus: 直接回到一个最窄的生物学问题：在同一组织中是否存在“先 senolytic、后 OSK”且同时报告功能改善与安全性读出的原始动物实验？ !! 被检查的 NEXT_FOCUS !! 下轮焦点（来自 mission `4360dd15` · Iter-0059） 继续逐篇核验 Europe PMC 命中的边缘记录，确认是否存在真正满足“同组织、先 senolytic 后 OSK、且有效应与安全读出”的原始实验。 "}, {"title": "老化干预要先找反馈回路", "tags": "lesson principle aging hematopoiesis niche", "mission": "4360dd15", "modified": "20260425035910000", "preview": "当一个组织的功能衰退同时涉及细胞本体和支持性微环境时，先把它当作双向反馈回路而不是单向瓶颈。干预方向必须分别验证“修复 niche 能否救回细胞”和“恢复细胞能否反过来修复 niche”，不要预设因果箭头。"}, {"title": "重编程效应要拆成炎症编辑与增殖激活两条轴", "tags": "lesson principle fact reprogramming wound-healing aging", "mission": "4360dd15", "modified": "20260425034206000", "preview": "评估 partial reprogramming 时，不要把“炎症/应激信号下降”自动等同于“细胞周期被激活”；这两者是可分离的轴，必须分别验证。对再生/抗衰干预而言，先确认它到底是在重置损伤相关状态，还是在真正推动增殖程序。"}, {"title": "NEXT_FOCUS-drifted-4360dd15-20260426-
→ call search_memory({"limit":8,"mission_only":true,"query":"senescence pro-regenerative niche sequence senolytic reprogramming OSK"})
【tool:search_memory】
{"ok": true, "results": [{"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率；在某些组织里，senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "relevance-drifting: 直接回到一个最窄的生物学问题：在同一组织中是否存在“先 senolytic、后 OSK”且同时报告功能改善与安全性读出的", "tags": "iteration relevance-check drifting", "mission": "4360dd15", "modified": "20260425172359000", "preview": "!! 目标相关性校准（drifting） verdict: **drifting** reason: 当前工作仍在为筛选可能的组织再生/抗衰老干预做证据核验，但最近几条标题已经明显转向检索约束、空检索和字段收缩这类方法论自转，离“找到让人类长生不老的方法”至少隔着数层证据筛选链条。 anchor_title: 检索要用字段收缩来验证结构性空集 rebase_focus: 直接回到一个最窄的生物学问题：在同一组织中是否存在“先 senolytic、后 OSK”且同时报告功能改善与安全性读出的原始动物实验？ !! 被检查的 NEXT_FOCUS !! 下轮焦点（来自 mission `4360dd15` · Iter-0059） 继续逐篇核验 Europe PMC 命中的边缘记录，确认是否存在真正满足“同组织、先 senolytic 后 OSK、且有效应与安全读出”的原始实验。 "}, {"title": "老化干预要先找反馈回路", "tags": "lesson principle aging hematopoiesis niche", "mission": "4360dd15", "modified": "20260425035910000", "preview": "当一个组织的功能衰退同时涉及细胞本体和支持性微环境时，先把它当作双向反馈回路而不是单向瓶颈。干预方向必须分别验证“修复 niche 能否救回细胞”和“恢复细胞能否反过来修复 niche”，不要预设因果箭头。"}, {"title": "重编程效应要拆成炎症编辑与增殖激活两条轴", "tags": "lesson principle fact reprogramming wound-healing aging", "mission": "4360dd15", "modified": "20260425034206000", "preview": "评估 partial reprogramming 时，不要把“炎症/应激信号下降”自动等同于“细胞周期被激活”；这两者是可分离的轴，必须分别验证。对再生/抗衰干预而言，先确认它到底是在重置损伤相关状态，还是在真正推动增殖程序。"}, {"title": "NEXT_FOCUS-drifted-4360dd15-20260426-
→ call task_add({"parent_id":"root","rationale":"沿着已证伪的同组织体内顺序实验继续向更可比的 ex vivo / organoid 体系收缩，判断是否存在可迁移的先 senolytic 后 OSK 证据。","title":"审计 ex vivo / organoid 中是否存在 senolytic 预处理后再做 OSK/partial reprogramming 的原始实验"})
【tool:task_add】
{"ok": true, "id": "n195", "parent": "root", "title": "审计 ex vivo / organoid 中是否存在 senolytic 预处理后再做 OSK/partial reprogramming 的原始实验", "status": "pending"}
→ call pubmed_search({"limit":10,"query":"(senolytic OR navitoclax OR ABT-263) (OSK OR OSKM OR partial reprogramming OR reprogramming) (organoid OR ex vivo OR explant OR organoid culture OR tissue slice)"})
【tool:pubmed_search】
{"ok": true, "query": "(senolytic OR navitoclax OR ABT-263) (OSK OR OSKM OR partial reprogramming OR reprogramming) (organoid OR ex vivo OR explant OR organoid culture OR tissue slice)", "results": [{"pmid": "40540718", "title": "Epigenetic Dysregulation and Osteocyte Senescence: Convergent Drivers of Osteosarcopenia in Aging Bone and Muscle.", "source": "Aging Dis", "pubdate": "2025 Jun 13", "authors": ["Nusrat S", "Din RU", "Tariq MA", "Yang H"], "url": "https://pubmed.ncbi.nlm.nih.gov/40540718/"}, {"pmid": "39312185", "title": "Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer Metastasis.", "source": "Cancer Res", "pubdate": "2024 Dec 2", "authors": ["Kaur J", "Adhikari M", "Sabol HM", "Anloague A", "Khan S", "Kurihara N", "Diaz-delCastillo M", "Andreasen CM"], "url": "https://pubmed.ncbi.nlm.nih.gov/39312185/"}, {"pmid": "38558984", "title": "Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer Metastasis.", "source": "Res Sq", "pubdate": "2024 Mar 14", "authors": ["Adhikari M", "Kaur J", "Sabol HM", "Anloague A", "Khan S", "Kurihara N", "Diaz-delCastillo M", "Andreasen CM"], "url": "https://pubmed.ncbi.nlm.nih.gov/38558984/"}, {"pmid": "35420133", "title": "Natural killer cells act as an extrinsic barrier for in vivo reprogramming.", "source": "Development", "pubdate": "2022 Apr 15", "authors": ["Melendez E", "Chondronasiou D", "Mosteiro L",
→ call web_search({"limit":10,"query":"senolytic preconditioning partial reprogramming organoid ex vivo OSK navitoclax"})
→ call web_search({"limit":10,"query":"\"partial reprogramming\" senolytic organoid"})
→ call web_search({"limit":10,"query":"ABT-263 OSK organoid ex vivo"})
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}
→ call pubmed_search({"limit":10,"query":"(senolytic OR navitoclax OR ABT-263) AND (organoid OR ex vivo OR explant OR tissue slice)"})
【tool:pubmed_search】
{"ok": true, "query": "(senolytic OR navitoclax OR ABT-263) AND (organoid OR ex vivo OR explant OR tissue slice)", "results": [{"pmid": "41979382", "title": "Clearance of Senescent Cells by BCL(XL)-PROTAC: A Novel Approach to Treat COPD?", "source": "Aging Cell", "pubdate": "2026 Apr", "authors": ["Devulder JV", "Fenwick PS", "Kolosionek E", "Al-Sahaf M", "Viola P", "Lemaire R", "Razdan N", "Kudo H"], "url": "https://pubmed.ncbi.nlm.nih.gov/41979382/"}, {"pmid": "41946679", "title": "Periosteal mitochondria DNA structures drive aging-associated poor skeletal repair.", "source": "Bone Res", "pubdate": "2026 Apr 7", "authors": ["Wu Y", "Han C", "Yang X", "Wang Y", "Tian W", "Yuan Q", "Wang H", "Wang H"], "url": "https://pubmed.ncbi.nlm.nih.gov/41946679/"}, {"pmid": "41698472", "title": "Head and Neck Squamous Cell Carcinoma Patient-Derived Cancer-Associated Fibroblasts Undergo Senescence While Retaining Protumorigenic Properties After Ex Vivo Irradiation.", "source": "Int J Radiat Oncol Biol Phys", "pubdate": "2026 Feb 14", "authors": ["Raaijmakers KTPM", "Peters RHW", "Beekmans M", "Beerkens APM", "Kaanders JHAM", "Honings J", "Weijs WLJ", "Adema GJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/41698472/"}, {"pmid": "41592680", "title": "Targeted delivery of senolytic drugs using macrophage membrane-camouflaged magnetic nanoparticles inhibits endplate sclerosis.", "source": "J Adv Res", "pubdate": "2026 Jan 25", "authors": ["Su W", "Shi C", "Pan Y", "Ma B", "Sun Y", "Fan M", "Zha
→ call pubmed_search({"limit":20,"query":"(\"partial reprogramming\" OR OSK OR OSKM) AND (organoid OR ex vivo OR explant OR slice OR tissue culture)"})
【tool:pubmed_search】
{"ok": true, "query": "(\"partial reprogramming\" OR OSK OR OSKM) AND (organoid OR ex vivo OR explant OR slice OR tissue culture)", "results": [{"pmid": "41892334", "title": "Harnessing Gut Endocrine Cell Plasticity to Restore Insulin Production.", "source": "Cells", "pubdate": "2026 Mar 19", "authors": ["Ayachi C", "Napolitano T", "Silvano S", "Giorgetti-Peraldi S", "Mansouri A", "Rapetti-Mauss R", "Fofo H", "Lepage V"], "url": "https://pubmed.ncbi.nlm.nih.gov/41892334/"}, {"pmid": "41871075", "title": "Refining fibroblast-to-cardiomyocyte transdifferentiation protocols to explore emergent self-organization in cardiac cultures.", "source": "PLoS One", "pubdate": "2026", "authors": ["Turchaninova E", "Robustova S", "Kovalenko S", "Dzhabrailov V", "Dolgodvorova A", "Romanova S", "Zybin D", "Popov M"], "url": "https://pubmed.ncbi.nlm.nih.gov/41871075/"}, {"pmid": "41645545", "title": "In Vitro, Ex Vivo and Clinical Trial of Brightening Serum Using a Novel Delivery System on Subjects With Moderate to Severe Dyschromia.", "source": "J Cosmet Dermatol", "pubdate": "2026 Feb", "authors": ["Bhatia AC", "Ortiz A", "Kannan S", "Moradi A", "Fleck T", "Love R", "Osborne S"], "url": "https://pubmed.ncbi.nlm.nih.gov/41645545/"}, {"pmid": "41632409", "title": "Early Reprogramming Intermediates Enable Direct Neuronal Conversion Via NGN2.", "source": "J Mol Neurosci", "pubdate": "2026 Feb 3", "authors": ["Angiolillo S", "Qin W", "Gesualdo A", "Frison R", "Elvassore N", "Laterza C", "Gagliano
→ call pubmed_search({"limit":20,"query":"(\"senolytic preconditioning\" OR \"senolytic pretreatment\" OR \"pretreated with navitoclax\" OR \"pretreated with ABT-263\") AND (reprogramming OR OSK OR OSKM OR \"partial reprogramming\")"})
【tool:pubmed_search】
{"ok": true, "query": "(\"senolytic preconditioning\" OR \"senolytic pretreatment\" OR \"pretreated with navitoclax\" OR \"pretreated with ABT-263\") AND (reprogramming OR OSK OR OSKM OR \"partial reprogramming\")", "results": []}
→ call task_fail({"id":"n195","reason":"PubMed exact preconditioning queries for senolytic→OSK/partial reprogramming in ex vivo/organoid/explant/slice contexts returned zero hits, and broader web search was unreachable, so I could not verify a real original ex vivo/organoid sequence experiment this round."})
【tool:task_fail】
{"ok": true, "id": "n195", "status": "failed", "next_focus": "root"}
→ call write_note({"tags":["fact","lesson","senolysis","reprogramming"],"text":"!! ex vivo / organoid 层面的 senolytic→partial reprogramming 检索门槛\n当要验证“先 senolytic、后 OSK/partial reprogramming”的顺序实验是否存在时，不能只查同文共现，必须把检索式显式写成预处理/先后顺序，并同时约束体系类型（organoid / ex vivo / explant / tissue slice）。若 PubMed 对 \\\"senolytic preconditioning\\\" / \\\"senolytic pretreatment\\\" + reprogramming/OSK/OSKM 返回零命中，而网页搜索又不可达，这一层目前应视为**未发现原始证)
【tool:write_note】
{"ok": true, "path": "/root/Sisyphus/wiki/tiddlers/senolytic_partial_reprogramming_的_ex_vivo_序贯证据门槛.tid", "title": "senolytic→partial reprogramming 的 ex vivo 序贯证据门槛"}
【assistant】
本轮完成了一个最小可验证收缩：
- 新增子任务：`n195 审计 ex vivo / organoid 中是否存在 senolytic 预处理后再做 OSK/partial reprogramming 的原始实验`
- 证据动作：
- PubMed 精确顺序检索 `senolytic preconditioning/pretreatment + reprogramming/OSK/OSKM` 返回 **0 hits**
- broader web search 受网络不可达限制，无法继续补网
- 结论：当前未能找到 ex vivo / organoid 层面的原始顺序实验；这层目前应记为**未发现证据**，不是默认存在
- 已沉淀一条可复用知识：`senolytic→partial reprogramming 的 ex vivo 序贯证据门槛`
<NEXT_FOCUS>继续沿着最窄问题回到“同一组织、先 senolytic 后 OSK、并有功能改善与安全读出”的原始动物实验核验，优先查是否存在可迁移的边缘正例。</NEXT_FOCUS>
========== REFLECTION ==========
{
"progress": "把检索范围从体内顺序实验收缩到 ex vivo / organoid 体系后，仍未找到 senolytic 预处理再接 OSK/partial reprogramming 的原始研究，证据缺口被进一步坐实。",
"failure": "最大的盲点是外网检索不可用，导致只能依赖 PubMed 题录层面核验，无法完成对边缘文献的全文级排除。",
"empirical_actions": "调用了 task_view、task_current、search_memory、task_add、pubmed_search 和 web_search；拿到的外部新数据是 PubMed 里若干相关但不直接匹配的题录，web_search 则全部返回网络不可达。",
"lesson": {
"worthy": false,
"title": "",
"extends_existing": "",
"tags": [],
"text": ""
},
"next_focus": "只做一件事：逐篇核验所有命中的边缘题录，确认是否存在真正满足“先 senolytic、后 OSK、且在同一 ex vivo 体系里同时有功能与安全读出”的原始实验。"
}